Innoviva (INVA) FCF Margin Growth (3y) (2014 - 2026)
Innoviva (INVA) FCF Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9,545.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.75 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -3,088.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4,612.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 14,060.00 |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn | -130,752.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -130,752.00 |
| Mar 31, 2026 | -135,329.00 |
| Sep 30, 2025 | -2,499.00 |
| Jun 30, 2025 | -187,966.00 |
| Mar 31, 2025 | -435,382.00 |
| Sep 30, 2024 | -4,500.00 |
| Jun 30, 2024 | -304,660.00 |
| Mar 31, 2024 | -387,169.00 |
| Sep 30, 2023 | -3,618.00 |
| Jun 30, 2023 | 124,954.00 |
| Mar 31, 2023 | 129,541.00 |
| Sep 30, 2022 | -1,469.00 |
| Jun 30, 2022 | 183,548.00 |
| Mar 31, 2022 | 426,976.00 |
| Sep 30, 2021 | -406.00 |
| Jun 30, 2021 | 301,326.00 |
| Mar 31, 2021 | 526,184.00 |
| Dec 31, 2020 | 1.69 Mn |
| Sep 30, 2020 | -534.00 |
| Jun 30, 2020 | 6,242.00 |